Gastrointestinal effects and acute toxicity of suprofen
- PMID: 1243036
Gastrointestinal effects and acute toxicity of suprofen
Abstract
The acute effects of orally administered, high doses of alpha-methyl-4-(2-thienylcarbonyl)benzeneacetic acid (suprofen) were studied in various tests, related to gastrointestinal functions. A decrease of the diarrheal stools in the castor oil test in rats was the first effect noted; the ED50 in this test was 40 mg/kg. This dose is 540 times higher than the ED50 of suprofen in the acetic acid-induced writhing test in rats (ED50 = 0.074 mg/kg). Temporarily decreased food consumption in rats was first noted after administration of 80 mg/kg. This is more than 1000 times the ED50 in the rat anti-writhing test. The appearance of gastrointestinal lesions was also studied in rats and a direct quantitative comparison was made with indometacin, acetyl-salicylic acid and ketoprofen. The dose of suprofen that produced lesions in 50% of the rats was 200 mg/kg, viz. 2700 times the ED50 in the rat anti-writhing test. Similarly obtained safety margins are 9.0 for indometacin, 78 for acetyl-salicylic acid and 102 for ketoprofen. The mortality after a single oral administration of suprofen was studied in mice, rats, guinea-pigs and dogs. LD50-values, based on mortality 7 days after administration, were 590 mg/kg, 353 mg/kg, 280 mg/kg and more than 160 mg/kg, respectively. Comparative LD50's in mice and rats were 14 and 19 mg/kg for indometacin, 280 and 70 mg/kg for ketoprofen. Therefore the safety margin in rats, with respect to the ED50 in the acetic acid-induced writhing test, is 4770 for suprofen, 156 for ketoprofen and 17.3 for indometacin. In guinea-pigs the safety margin of suprofen is 1470 with respect to the ED50 in UV-erythema and in dogs more than 250 with respect to the ED50 in urate-induced arthritis. From these data we may conclude that suprofen is comparatively safer than the reference compounds studied and that its effects on the gastrointestinal tract appear at doses far above those required for effectiveness in tests related to pain, fever and inflammation.
Similar articles
-
Suprofen, a potent antagonist of acetic acid-induced writhing in rats.Arzneimittelforschung. 1975 Oct;25(10):1505-9. Arzneimittelforschung. 1975. PMID: 1243029
-
The effects of suprofen in rats with Mycobacterium butyricum-induced arthritis.Arzneimittelforschung. 1975 Oct;25(10):1526-37. Arzneimittelforschung. 1975. PMID: 1243035
-
Suprofen, a potent antagonist of sodium urate crystal-induced arthritis in dogs.Arzneimittelforschung. 1975 Oct;25(10):1512-5. Arzneimittelforschung. 1975. PMID: 1243031
-
Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.Int J Toxicol. 2007;26 Suppl 1:3-106. doi: 10.1080/10915810601163939. Int J Toxicol. 2007. PMID: 17365137 Review.
-
The pharmacological properties of fenbufen. A review.Arzneimittelforschung. 1980;30(4A):716-21. Arzneimittelforschung. 1980. PMID: 7002162 Review.
Cited by
-
A national validation study of the acute-toxic-class method--an alternative to the LD50 test.Arch Toxicol. 1992;66(7):455-70. doi: 10.1007/BF01970670. Arch Toxicol. 1992. PMID: 1444812 Review.
-
Conformational turn triggers regio-selectivity in the bioactivation of thiophene-contained compounds mediated by cytochrome P450.J Biol Inorg Chem. 2019 Oct;24(7):1023-1033. doi: 10.1007/s00775-019-01699-6. Epub 2019 Sep 10. J Biol Inorg Chem. 2019. PMID: 31506822
-
Suprofen. A review of its pharmacodynamic and pharmacokinetic properties, and analgesic efficacy.Drugs. 1985 Dec;30(6):514-38. doi: 10.2165/00003495-198530060-00004. Drugs. 1985. PMID: 3908075 Review.
-
Behavioral Battery for Testing Candidate Analgesics in Mice. I. Validation with Positive and Negative Controls.J Pharmacol Exp Ther. 2021 May;377(2):232-241. doi: 10.1124/jpet.120.000464. Epub 2021 Feb 23. J Pharmacol Exp Ther. 2021. PMID: 33622770 Free PMC article.